Nath Bio-Genes (India) Limited NATHBIOGEN NSEINFRA
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win-Chi-Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company was founded in 1979 and is based in Mumbai, India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Compounding revenue at 13.9% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NATHBIOGEN Nath Bio-Genes (India) Limited NSEINFRA | 175.18 | 8.35 | ₹333.37 Cr | 1.14% | 8.86% | 6.29% | 13.88% | 5.94% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 11,482.00 | 41.32 | ₹3.38 L Cr | 0.67% | 11.90% | 10.59% | 12.40% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,278.00 | 14.01 | ₹3.12 L Cr | 0.56% | 19.15% | 27.26% | 3.61% | 75.28% |
| 4 | HINDZINC Hindustan Zinc Limited NSEINFRA | 632.95 | 19.34 | ₹2.67 L Cr | 3.32% | 62.35% | 76.94% | 5.61% | 9.58% |
| 5 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 208.02 | 28.34 | ₹2.59 L Cr | 1.92% | 11.32% | 11.16% | -1.59% | 7.21% |
| 6 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 1,126.70 | 18.73 | ₹2.52 L Cr | 0.44% | 9.50% | 10.29% | 7.40% | 9.87% |
| 7 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 3,122.40 | 42.74 | ₹2.12 L Cr | 0.32% | 4.00% | 6.29% | 14.63% | -10.06% |
| 8 | SOLARINDS Solar Industries India Limited NSEINFRA | 18,247.00 | 98.04 | ₹1.65 L Cr | 0.06% | 29.51% | 31.33% | 13.27% | 30.36% |
| 9 | PIDILITIND Pidilite Industries Limited NSEINFRA | 1,482.80 | 61.73 | ₹1.51 L Cr | 0.67% | 28.48% | 23.52% | 7.50% | 24.36% |
Quarterly Results
Figures in INR.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 51.97 Cr | 283.70 Cr | 43.85 Cr | 65.96 Cr | 51.59 Cr |
| Cost of Revenue | 17.68 Cr | 139.82 Cr | 17.11 Cr | 28.78 Cr | 15.80 Cr |
| Gross Profit | 34.29 Cr | 143.88 Cr | 26.74 Cr | 37.18 Cr | 35.79 Cr |
| Operating Expenses | 35.22 Cr | 106.57 Cr | 21.63 Cr | 34.58 Cr | 32.34 Cr |
| Operating Income | -92.80 L | 37.31 Cr | 5.12 Cr | 2.60 Cr | 3.45 Cr |
| EBITDA | 4.28 Cr | 40.05 Cr | 10.10 Cr | 8.00 Cr | 8.11 Cr |
| Interest Expense | 1.37 Cr | 3.20 Cr | 3.66 Cr | 4.54 Cr | 4.59 Cr |
| Pretax Income | 1.57 Cr | 35.88 Cr | 5.46 Cr | 2.48 Cr | 2.49 Cr |
| Tax Provision | 62.73 L | 65.97 L | 64.11 L | 87.28 L | 2.50 Cr |
| Net Income | 1.48 Cr | 37.28 Cr | 2.75 Cr | 1.60 Cr | -89,000 |
| Diluted EPS | 0.42 | 19.58 | 1.40 | 0.84 | -0.79 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 301.36 Cr | 332.62 Cr | 364.91 Cr | 445.10 Cr |
| Cost of Revenue | - | 114.61 Cr | 113.57 Cr | 135.55 Cr | 201.50 Cr |
| Gross Profit | - | 186.75 Cr | 219.05 Cr | 229.36 Cr | 243.60 Cr |
| Operating Expenses | - | 140.72 Cr | 172.22 Cr | 183.38 Cr | 195.12 Cr |
| Operating Income | - | 46.04 Cr | 46.84 Cr | 45.98 Cr | 48.47 Cr |
| EBITDA | - | 51.76 Cr | 56.72 Cr | 54.34 Cr | 66.26 Cr |
| Interest Expense | - | 9.57 Cr | 8.63 Cr | 10.48 Cr | 15.99 Cr |
| Pretax Income | - | 36.16 Cr | 41.56 Cr | 40.04 Cr | 46.30 Cr |
| Tax Provision | - | 1.15 Cr | 1.95 Cr | 1.98 Cr | 4.67 Cr |
| Net Income | - | 35.01 Cr | 39.62 Cr | 38.60 Cr | 41.63 Cr |
| Diluted EPS | - | 18.43 | 20.85 | 20.14 | 20.98 |
Compounded Sales Growth
| 5 Years: | 13.88% |
| 1 Year: | -1.00% |
Compounded Profit Growth
| 5 Years: | 5.94% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -5.93% |
| 6 Months: | +10.80% |
| 3 Months: | +19.03% |
| 1 Month: | +1.85% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 792.80 Cr | 880.23 Cr | 1,026.21 Cr | 1,097.42 Cr |
| Current Assets | - | 519.83 Cr | 571.66 Cr | 690.01 Cr | 778.86 Cr |
| Cash & Equivalents | - | 37.99 Cr | 77.13 Cr | 88.53 Cr | 76.00 Cr |
| Inventory | - | 207.85 Cr | 230.31 Cr | 338.02 Cr | 450.55 Cr |
| Receivables | - | 97.31 Cr | 94.31 Cr | 88.90 Cr | 85.41 Cr |
| Total Liabilities | - | 219.62 Cr | 270.31 Cr | 381.82 Cr | 416.96 Cr |
| Current Liabilities | - | 216.43 Cr | 262.45 Cr | 365.30 Cr | 394.70 Cr |
| Long Term Debt | - | 40.32 L | 4.87 Cr | 12.98 Cr | 17.32 Cr |
| Total Debt | - | 105.21 Cr | 110.35 Cr | 122.50 Cr | 138.50 Cr |
| Total Equity | - | 573.17 Cr | 609.92 Cr | 644.39 Cr | 680.46 Cr |
| Shares Outstanding | - | 1.90 Cr | 1.90 Cr | 1.90 Cr | 1.90 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 38.37 Cr | 74.59 Cr | 17.58 Cr | -12.57 Cr |
| Investing Cash Flow | - | -2.88 Cr | -27.40 Cr | -3.96 Cr | 3.46 Cr |
| Financing Cash Flow | - | -1.67 Cr | -7.78 Cr | -2.13 Cr | -3.79 Cr |
| Capital Expenditure | - | -2.55 Cr | -26.78 Cr | -7.92 Cr | -3.01 Cr |
| Free Cash Flow | - | 35.82 Cr | 47.82 Cr | 9.66 Cr | -15.58 Cr |
| Net Change in Cash | - | 33.81 Cr | 39.41 Cr | 11.49 Cr | -12.90 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 62.0% | 65.9% | 62.9% | 54.7% |
| Operating Margin % | - | 15.3% | 14.1% | 12.6% | 10.9% |
| Net Margin % | - | 11.6% | 11.9% | 10.6% | 9.4% |
| ROE % | - | 6.1% | 6.5% | 6.0% | 6.1% |
| ROCE % | - | 8.0% | 7.6% | 7.0% | 6.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NATHBIOGEN